OVERVIEW

22nd Annual Lynn Sage Breast Cancer Symposium is organized by Robert H. Lurie Comprehensive Cancer Center of Northwestern University. This Online CME Course will be held from Sep 10 - 12, 2020.

How many CME credits can be earned by attending the 22nd Annual Lynn Sage Breast Cancer Symposium?

Accreditation:
The Northwestern University Feinberg School of Medicine assigns this live activity for a maximum of 16.25 AMA PRA Category 1 Credit(s)™. Physicians will be able to claim the redit commensurate based on the extent of their participation in the activity.

Maintenance of Certification (MOC)
On successful completion of this CME activity, participants in the session will be able to apply for the evaluation component, allowing them to earn up to 16.25 MOC points [and patient safety MOC credit] in the American Board of Internal Medicine's (ABIM) MOC program.

What is the significance of the 22nd Annual Lynn Sage Breast Cancer Symposium?

Course Overview:
For over 20 years, this multidisciplinary CME session has contributed the most advanced information concerning cutting-edge technology and strategies in the management of breast cancer from leading national and international medical, surgical, and radiation oncologists. This year's conference will be no different. The virtual symposium will comprise a superb line-up of internationally accepted faculty who will not only present the latest research findings but will also be ready for real-time interaction following their presentations.

Progress across all aspects of patient care, along with the prevention, screening, detection, and survivorship, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies are leading to new procedures and therapeutic options.

The symposium will converge on the close cooperation needed for effective multidisciplinary management of patients with breast cancer.

What are the objectives of the 22nd Annual Lynn Sage Breast Cancer Symposium?

Learning Objectives:
• Review optimal evaluation and management of women at heightened risk for breast cancer.
• Examine the application of neoadjuvant endocrine therapy inoperable cancer.
• Define the role of the latest technology in radiology and radiotherapy.
• Recognize dissimilar approaches to systemic therapy and how they may influence surgical management.